APA aipamena

Tatosian, D. A., Guo, Y., Schaeffer, A. K., Gaibu, N., Popa, S., Stoch, A., . . . Kauh, E. A. (2013). Dipeptidyl Peptidase-4 Inhibition in Patients with Type 2 Diabetes Treated with Saxagliptin, Sitagliptin, or Vildagliptin. Springer Healthcare.

Chicago Style aipamena

Tatosian, Daniel A., Ying Guo, Andrea K. Schaeffer, Natalia Gaibu, Serghei Popa, Aubrey Stoch, Ronald B. Langdon, and Eunkyung A. Kauh. Dipeptidyl Peptidase-4 Inhibition in Patients With Type 2 Diabetes Treated With Saxagliptin, Sitagliptin, or Vildagliptin. Springer Healthcare, 2013.

MLA aipamena

Tatosian, Daniel A., et al. Dipeptidyl Peptidase-4 Inhibition in Patients With Type 2 Diabetes Treated With Saxagliptin, Sitagliptin, or Vildagliptin. Springer Healthcare, 2013.